Study Stopped
The study never started since our Medical Ethic Commeettee did not approved it
ATLANTIS:Extensive Type A Dissections and Thoracic/ Thoraco-Abdominal Aneurysms Repair With LupiAe Hybrid TechNique
ATLANTIS
Extensive Type A Dissections and Thoracic/ Thoraco-Abdominal
1 other identifier
interventional
120
1 country
1
Brief Summary
To prospectively evaluate the safety and efficacy of the LUPIAE hybrid technique for the treatment of
- thoracic or thoraco-abdominal aortic aneurysms
- thoracic aortic type A dissections 2. to compare the safety and efficacy of the LUPIAE hybrid technique with historical groups (literature review, other hybrid techniques, LUPIAE retrospective patients)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_4
Started Jun 2010
Typical duration for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 20, 2010
CompletedFirst Posted
Study publicly available on registry
April 21, 2010
CompletedStudy Start
First participant enrolled
June 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2012
CompletedJune 28, 2011
June 1, 2011
2.5 years
April 20, 2010
June 27, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
all cause mortality
12 months
Interventions
it's a new hybrid technique for the treatment of aortic aneurism and dissection.
Eligibility Criteria
You may qualify if:
- Patient willing to sign the informed consent, or In case of acute patients that should arrive at the hospital in unconsciousness status, patient's first degree relatives willingness to sign the informed consent and patient's willingness to re-consent for the study participation once he/she is again conscious.
- and
- Patients with extensive thoracic or thoraco-abdominal aortic aneurysms (\>55 mm diameter), involving the ascending, arch and descending aortic segments, but not involving the renal arteries (at least 15 mm of healthy tissue above the most proximal renal artery).
- Patients with extensive type A aortic dissection (DeBakey type I) with at least one of the following minimum criteria:
- An initial false lumen diameter measured in the upper descending thoracic aorta \>22 mm;
- Total aortic diameter measured in the descending thoracic aorta \>45 mm;
- True lumen's compression (True lumen \<10% of total aortic lumen);
- Non-controlled hypertension;
- Persistent pain;
- Rupture or imminent rupture;
You may not qualify if:
- Patient has a standard contraindication to the implant of thoracic stent graft;
- Patient unable to commit to follow-up schedule;
- Patient has medical conditions that preclude protocol required testing or limit study participation;
- Patient is enrolled or intend to participate in another clinical trial during the course of this study;
- Less than 18 years of age;
- Pregnancy;
- A life expectancy of less than one year, except for Patients with extensive type A aortic dissection (DeBakey type I)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Policlinico S Orsola Malpighi
Bologna, Italy, 40138, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
April 20, 2010
First Posted
April 21, 2010
Study Start
June 1, 2010
Primary Completion
December 1, 2012
Study Completion
December 1, 2012
Last Updated
June 28, 2011
Record last verified: 2011-06